Core Insights - Interface reported a record year in 2025 with all-time highs in net sales, adjusted operating income, and adjusted EBITDA, driven by broad-based regional and segment growth, price and volume gains across all product categories, and operational improvements [4][7] Financial Performance - For the full year 2025, Interface achieved net sales of $1.39 billion, a 5.4% increase year-over-year, with adjusted EBITDA of $217.9 million and adjusted EPS of $1.94, reflecting a 33% increase [7][17] - Fourth-quarter net sales were $349.4 million, up 4.3% as reported and 1.6% on a currency-neutral basis, with adjusted gross margin at 38.6%, up 169 basis points [13][14] Growth Drivers - Global healthcare billings increased by 21% year-over-year in 2025, while education billings rose by 8%, attributed to expanded offerings at more approachable price points [1] - The combined U.S. selling team model across carpet tile, LVT, and nora Rubber has enhanced cross-selling effectiveness, contributing to a 17% increase in global rubber billings [2] Strategic Initiatives - The "One Interface" strategy focuses on strengthening global functions to support local selling teams, improving commercial productivity, and expanding margins through global supply chain management [3] - Interface launched "noravant," a PVC-free rubber sheet platform, expected to contribute $5–10 million in 2026 and potentially $50–100 million over five years [6][9] Capital Allocation and Outlook - For 2026, Interface projects net sales of $1.42–$1.46 billion and capital expenditures of about $55 million, while also extending its debt and increasing the quarterly dividend to $0.03 per share [5][19] - The company entered 2026 with solid orders and a healthy backlog, up 7% year-to-date, despite macroeconomic uncertainties [19] Sustainability Efforts - Sustainability remains a central theme, with Interface offering low-carbon products and incorporating captured carbon in manufacturing processes, recognized in various sustainability rankings [12]

Financial Data and Key Metrics Changes - In 2025, the company achieved record net sales, Adjusted Operating Income, and Adjusted EBITDA, with currency-neutral net sales increasing by 4% year-over-year [4][14] - Full year net sales totaled $1.39 billion, up 5.4%, with currency-neutral net sales in the Americas increasing by 5.5% and in EAAA by 2.4% [21][22] - Adjusted gross profit margin increased to 39%, up 187 basis points, driven by favorable pricing and manufacturing efficiencies [22] - Adjusted EPS for the fourth quarter was $0.49, up 44.1% compared to $0.34 [19] Business Line Data and Key Metrics Changes - All three product categories (carpet tile, LVT, and nora Rubber) experienced growth in both price and volume [5] - Global rubber billings increased by 17% in 2025 compared to the prior year [6] - Healthcare billings were up 21% year-over-year, while education billings increased by 8% [14][15] Market Data and Key Metrics Changes - In the Americas, currency-neutral net sales increased by 5% year-over-year, particularly strong in healthcare and education segments [14] - EAAA region saw a 2% increase in currency-neutral net sales, reflecting improving trends despite a challenging macro environment [14] - Corporate office billings were slightly up, with a focus on Class A spaces [15] Company Strategy and Development Direction - The company is committed to the "One Interface" strategy, focusing on global functions to support local selling teams and enhancing commercial productivity [4] - Continued investments in automation and robotics are expected to drive productivity gains and margin expansion [7][8] - The launch of Noravant, a new rubber flooring innovation, aims to expand the addressable market in the resilient category [9][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the scalability of the combined selling team model, particularly in healthcare and education [7] - The company anticipates continued growth driven by strong demand in healthcare and education, supported by macro tailwinds [15][16] - For 2026, the company expects net sales of $1.42 billion to $1.46 billion, with an adjusted gross profit margin of approximately 38.5%-39% [28][29] Other Important Information - The company generated $167.9 million in cash from operating activities in 2025, compared to $148.4 million in 2024 [24] - Capital expenditures for 2025 were $46.2 million, with an expected increase to $55 million in 2026 to support automation initiatives [25] - The board approved an increase in the quarterly dividend from $0.02 to $0.03 per share, reflecting confidence in cash flow generation [26] Q&A Session Summary Question: Can you talk about the One Interface selling strategy? - Management highlighted the success of the combined selling teams in the U.S., with healthcare billings up 21% and nora business up 17% [34] Question: Can you discuss gross margins for 2026? - Management noted that gross margins achieved 38.5%, with expectations for continued expansion driven by automation and efficiency initiatives [36][38] Question: How is the corporate market performing compared to healthcare and education? - Management indicated that the corporate business was flat, with retail business being soft, but healthcare and education showed strong growth [46][47] Question: Can you provide details on the backlog increase? - Management described the backlog as solid and well-distributed across initiatives, providing confidence entering 2026 [50][51] Question: How is SG&A being managed while pursuing growth? - Management emphasized disciplined spending and variable compensation tied to revenue, ensuring efficient use of resources [54][55] Question: What is the impact of tariffs on gross margins? - Management indicated that tariffs diluted gross profit percentage by around 20 basis points in 2025, with an anticipated 50 basis points impact in 2026 [91] Question: Can you provide global billings by category for Q4? - Management reported that corporate was flat, education was up 11.6%, and healthcare was up 11.7% [105]

Financial Data and Key Metrics Changes - In 2025, the company achieved record net sales, adjusted operating income, and adjusted EBITDA, marking the highest levels in its history [4] - Full year net sales totaled $1.39 billion, up 5.4%, with currency-neutral net sales increasing 4.3% [21] - Adjusted gross profit margin increased to 39%, up 187 basis points, driven by favorable pricing and manufacturing efficiencies [22] - Adjusted EPS for the fourth quarter was $0.49, up 44.1% compared to $0.34 [19] Business Line Data and Key Metrics Changes - All three product categories (carpet tile, LVT, and rubber) grew in both price and volume [5] - Global healthcare billings were up 21% year-over-year, with double-digit gains in the Americas and EAAA [14] - Education billings increased 8% for the full year, reflecting the success of expanded collection offerings [15] - Corporate office billings were up slightly for the year, with a focus on gaining share in Class A spaces [15] Market Data and Key Metrics Changes - Currency-neutral net sales in the Americas increased 5.5%, while EAAA saw a 2.4% increase [21] - The company reported a 2% increase in consolidated currency-neutral orders year-over-year [20] - The healthcare and education sectors are experiencing increased investment, driven by aging populations and modernization efforts [15] Company Strategy and Development Direction - The "One Interface" strategy focuses on building strong global functions to support local selling teams and enhancing commercial productivity [4] - The company is committed to sustainability, with initiatives including the launch of a cradle-to-gate carbon negative rubber prototype [12] - The introduction of the noravant product line is expected to open new design possibilities and expand the addressable market [9][10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the scalability of the combined selling team model, particularly in healthcare and education [7] - The company anticipates continued growth in 2026, with a focus on expanding its addressable market through innovative products and pricing strategies [16] - Management acknowledged ongoing macro uncertainties but highlighted a solid order backlog and healthy growth expectations [27] Other Important Information - The company plans to increase capital expenditures to $55 million in 2026 to support automation and productivity initiatives [25] - A quarterly dividend increase from $0.02 to $0.03 per share was approved, reflecting confidence in cash flow generation [26] Q&A Session Summary Question: Can you talk about the One Interface selling strategy? - Management highlighted the success of the combined selling teams, with healthcare billings up 21% and expectations for continued growth through the launch of noravant [35][36] Question: Can you discuss gross margins for 2026? - Management noted that gross margins achieved 38.5%, with expectations for continued expansion driven by automation and efficiency initiatives [38][39] Question: What is the outlook for the corporate market? - Management indicated that the corporate market remains competitive, with growth expectations aligned with strong demand in Class A spaces [48] Question: Can you elaborate on the backlog increase? - Management described the backlog as solid and well-distributed across various initiatives, providing confidence for entering 2026 [51][53] Question: How is the company managing SG&A expenses? - Management emphasized a disciplined approach to SG&A, focusing on investments that drive growth while maintaining efficiency [56][57] Question: What is the impact of tariffs on gross margins? - Management indicated that tariffs had a dilutive impact on gross profit percentage, with expectations for modest inflation in raw materials [95][96]

Financial Data and Key Metrics Changes - 2025 was a record year for the company, with net sales, Adjusted Operating Income, and Adjusted EBITDA reaching their highest levels in history, driven by the One Interface strategy [4] - Full year net sales totaled $1.39 billion, up 5.4%, with currency-neutral net sales increasing 4.3% [18] - Adjusted gross profit margin increased to 39%, up 187 basis points, driven by favorable pricing and manufacturing efficiencies [19] - Adjusted EPS was $1.94, a 33% increase compared to $1.46 [20] Business Line Data and Key Metrics Changes - All three product categories (carpet tile, LVT, and rubber) grew in both price and volume, with global rubber billings up 17% in 2025 [5][12] - Healthcare billings were up 21% year-over-year, while education billings increased 8% [12][13] - Corporate office billings were up slightly, reflecting a competitive market environment [14] Market Data and Key Metrics Changes - Currency-neutral net sales in the Americas increased 5.5%, while EAAA saw a 2.4% increase, indicating improving trends in international markets [18] - The healthcare sector is experiencing increased investment due to aging populations and a focus on preventative care, benefiting the company [13] - The corporate market remains competitive, with Class A spaces in demand, particularly in major cities like New York and San Francisco [44][64] Company Strategy and Development Direction - The One Interface strategy focuses on building strong global functions to support local selling teams, enhancing commercial productivity, and expanding margins through supply chain management [4] - The company is committed to sustainability, with a focus on low-carbon products and innovative solutions like the new Noravant rubber flooring [11][9] - Future growth will be driven by expanding addressable markets through innovative product offerings and maintaining a disciplined approach to SG&A expenses [15][21] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the scalability of the combined selling team model, particularly in healthcare and education markets [6] - The company anticipates continued growth in 2026, with a focus on leveraging successful strategies and expanding product offerings [14][24] - Management acknowledged ongoing macro uncertainties but remains optimistic about solid orders and a healthy backlog entering 2026 [24] Other Important Information - The company generated $167.9 million in cash from operating activities in 2025, compared to $148.4 million in 2024 [21] - Capital expenditures were $46.2 million in 2025, with expectations to increase to $55 million in 2026 to support automation and productivity initiatives [22] - The quarterly dividend was increased from $0.02 to $0.03 per share, reflecting confidence in cash flow generation [23] Q&A Session Summary Question: Can you elaborate on the One Interface selling strategy? - Management highlighted the success of the combined selling teams and the potential for further expansion in healthcare and education markets [29][30] Question: What are the expectations for gross margins in 2026? - Management indicated that gross margins are expected to continue improving, driven by automation and efficiency initiatives [33][34] Question: How is the corporate market performing compared to healthcare and education? - Management noted that while corporate business was flat, healthcare and education saw significant growth, with ongoing demand in Class A spaces [42][44] Question: Can you provide details on the backlog increase? - Management described the backlog as solid and well-distributed across various initiatives, providing confidence for 2026 [47][49] Question: How is SG&A being managed while pursuing growth opportunities? - Management emphasized disciplined spending and a focus on variable compensation tied to revenue, ensuring efficiency [52][56] Question: What is the impact of tariffs on gross margins? - Management indicated that tariffs had a dilutive impact on gross profit percentage, with expectations for continued monitoring and adjustments [93][94]

Financial Data and Key Metrics Changes - Third quarter net sales were $364.5 million, up 5.9% as reported and 4.2% on a currency-neutral basis compared to the third quarter of 2024, both exceeding expectations [13] - Adjusted gross profit margin was 39.5%, an increase of 208 basis points year over year, driven by favorable pricing and product mix along with manufacturing efficiencies [14] - Adjusted operating income rose to $54.1 million, reflecting a 24.5% year-over-year increase [14] - Adjusted EBITDA for the third quarter was $66.2 million, compared to $53.7 million in the same quarter of 2024 [15] - Adjusted earnings per share increased by 27% to $0.61 from $0.48 in the third quarter of 2024 [15] - The company ended the quarter with $482 million in liquidity and a net leverage ratio of 0.6 times [15] Business Line Data and Key Metrics Changes - The nora rubber segment grew by 20% in the third quarter and is up 19% year to date, driven by the One Interface strategy [5] - Corporate office billings increased by 5% in the third quarter, with year-to-date growth expected [9] - Global healthcare billings surged by 29%, with double-digit gains across both the Americas and EAAA [9] - Education billings saw a slight decline of less than 3% in the third quarter but remain at high single digits year to date [10] Market Data and Key Metrics Changes - In the Americas, currency-neutral net sales increased by 4.1% year over year, while EAAA saw a 4.3% increase [13] - Consolidated currency-neutral orders rose by 2.4% year over year, with the Americas up 1.7% and EAAA up 3.5% [10] Company Strategy and Development Direction - The company is focused on its One Interface strategy, which aims to build strong global functions to support local selling teams and enhance commercial productivity [5] - Investments in automation, productivity, and innovation are being accelerated to strengthen the nora product portfolio and drive long-term growth [6] - The company is preparing to launch a new rubber flooring innovation in early 2026, targeting growth in the healthcare segment [6] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's strategy and disciplined execution, highlighting strong results despite a challenging macro environment [11] - The company is raising its full-year guidance based on year-to-date results, anticipating net sales of $1.375 to $1.390 billion for the fiscal year 2025 [17] Other Important Information - The company received multiple awards for design and sustainability, including Manufacturer of the Year in ED's Net Zero Awards [11] - Tariffs diluted the adjusted gross profit percentage by approximately 30 basis points in the third quarter, with a similar dilution expected in the fourth quarter [16] Q&A Session Summary Question: What drove the sales outperformance this quarter? - Management noted that healthcare was the outperformer, with a 29% increase, exceeding expectations due to a focus on expanding the product portfolio in that segment [21][23] Question: Can you provide more details on investments in nora rubber? - Management confirmed ongoing investments in capacity, productivity initiatives, and innovation to support the growth of the nora rubber business [25][26] Question: How do you view margins going forward? - Management indicated that while they aim for a gross profit margin of 38.5%, they will balance share growth and business expansion [28] Question: Can you provide insights on the tax rate and special items in Q3? - The unusual tax rate of 4.8% was due to a non-cash pickup related to changes in German tax legislation, which required remeasuring deferred tax assets and liabilities [39][40] Question: What is the outlook for capital expenditures in 2026? - Management anticipates a slight increase in capital expenditures, primarily associated with nora rubber and other automation investments [74][76]

Financial Data and Key Metrics Changes - Interface reported currency neutral net sales growth of 7% and adjusted earnings per share of $0.60, both exceeding expectations [5][14] - Second quarter net sales totaled $375.5 million, an increase of 8.3% year-over-year, with adjusted gross profit margin at 39.8%, up 402 basis points from the previous year [21][22] - Adjusted operating income rose to $55.9 million, a 41% increase compared to the previous year, while adjusted EBITDA was $64.8 million [22][24] Business Line Data and Key Metrics Changes - The Americas team achieved 11% sales growth, with significant market share gains in carpet tile and rubber, particularly a near 40% growth in Nora Rubber [6][14] - Global education billings increased by 11% year-over-year, while health care billings surged by 28% [15][16] - Corporate office billings returned to growth, up 3% year-over-year, reflecting ongoing investments in workplace refreshes [18] Market Data and Key Metrics Changes - Currency neutral consolidated orders were up 3% year-over-year, with a 2% increase in The Americas and a 4% increase in EAAA [19] - The backlog increased by 24% year-to-date, positioning the company strongly for future sales growth [19][67] Company Strategy and Development Direction - The "One Interface" strategy focuses on building strong global functions to support local selling teams, enhancing productivity, and expanding margins through global supply chain management [5][6] - The company is committed to strategic investments in automation and robotics to improve operational efficiency and support sustainable growth [9][10] - Interface aims to be carbon negative by 2040, having already reduced its carbon footprint significantly across various product lines [12][13] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's position despite a dynamic macro environment, highlighting strong performance in The Americas and encouraging order growth in EAAA [14][31] - The company raised its full-year guidance based on strong Q2 results, anticipating net sales of $1.37 billion to $1.39 billion for the fiscal year [24][25] - Management emphasized the importance of maintaining a balanced capital allocation strategy while investing in growth and margin expansion [23][40] Other Important Information - Interface repurchased $4.3 million of common stock in the quarter, marking the first repurchase since 2022 [23][39] - The company is focused on expanding its addressable market through product offerings at more approachable price points [7][8] Q&A Session Summary Question: What was the shape of Q2 performance on a similar basis? - Management noted that order growth momentum was strong in April, saw a slight dip in May and June, but picked back up, with July also showing strong order growth [30][31] Question: Can you provide color on government and retail performance in Q2? - Management indicated that almost every market saw growth, including government and retail, with corporate, education, and health care being the primary markets [32][34] Question: What are the business conditions in Australia and Asia? - Management reported strong business conditions in Australia and Asia, with local teams and manufacturing mitigating macro impacts [36][37] Question: What are the plans for capital allocation regarding share repurchases? - Management confirmed that while the primary focus is on investing in the business, they will also return capital to shareholders through share repurchases and dividends [38][40] Question: Is the "One Interface" strategy at full run rate? - Management believes the strategy is still in the early stages, with significant growth potential remaining, particularly in the Nora Rubber business [44][47] Question: What drove the margin performance in the quarter? - Management attributed margin expansion to a combination of pricing, product mix, and manufacturing productivity, with a significant portion driven by operational excellence [48][50] Question: Was there any pull forward of sales in Q2? - Management stated there was no awareness of any sales being pulled forward, although some larger orders in health care may have contributed to lumpiness [59][60] Question: How sustainable are the market share gains? - Management expressed confidence in the sustainability of market share gains, supported by strong product offerings and a focus on expanding into mid-market price points [63][64] Question: What is the timeline for the backlog? - Most of the backlog is expected to ship within the year, with some longer-term contracts included [67] Question: What are the expected returns on investment in international manufacturing assets? - Management indicated that benefits from automation in The Americas will start to be seen in Europe and Australia next year [71] Question: What is the impact of tariffs on gross margins? - The impact of tariffs was largely neutral in the quarter, with some expenses offset by incremental pricing [72] Question: How does the company view the buy versus build decision for growth? - Management emphasized a focus on internal growth and innovation, while remaining open to acquisitions if they align with strategic goals [76]

Core Insights - Interface reported quarterly earnings of $0.6 per share, exceeding the Zacks Consensus Estimate of $0.47 per share, and showing an increase from $0.4 per share a year ago, resulting in an earnings surprise of +27.66% [1] - The company achieved revenues of $375.52 million for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 4.31%, compared to $346.64 million in the same quarter last year [2] - Interface has consistently surpassed consensus EPS estimates over the last four quarters, achieving this four times [2] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $0.48 on revenues of $352 million, and for the current fiscal year, it is $1.58 on revenues of $1.35 billion [7] - The estimate revisions trend for Interface was mixed ahead of the earnings release, resulting in a Zacks Rank 3 (Hold) for the stock, indicating expected performance in line with the market [6] Industry Context - The Textile - Home Furnishing industry, to which Interface belongs, is currently in the top 40% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Core Viewpoint - Mohawk Industries reported quarterly earnings of $2.77 per share, exceeding the Zacks Consensus Estimate of $2.62 per share, but down from $3 per share a year ago, indicating a +5.73% earnings surprise [1][2] Financial Performance - The company achieved revenues of $2.8 billion for the quarter ended June 2025, surpassing the Zacks Consensus Estimate by 0.37%, consistent with year-ago revenues [2] - Over the last four quarters, Mohawk Industries has surpassed consensus EPS estimates four times and topped consensus revenue estimates three times [2] Stock Performance - Mohawk Industries shares have declined approximately 2.1% since the beginning of the year, contrasting with the S&P 500's gain of 8.1% [3] - The current Zacks Rank for Mohawk Industries is 3 (Hold), indicating expected performance in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is $2.74 on revenues of $2.73 billion, and for the current fiscal year, it is $9.13 on revenues of $10.77 billion [7] - The trend of estimate revisions for Mohawk Industries was mixed ahead of the earnings release, which may change following the recent report [6] Industry Context - The Textile - Home Furnishing industry, to which Mohawk Industries belongs, is currently in the top 39% of over 250 Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]

分组1 - Interface reported quarterly earnings of $0.25 per share, exceeding the Zacks Consensus Estimate of $0.20 per share, and showing a slight increase from $0.24 per share a year ago, resulting in an earnings surprise of 25% [1] - The company achieved revenues of $297.41 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 0.82%, and an increase from $289.74 million year-over-year [2] - Interface has consistently surpassed consensus EPS estimates over the last four quarters, achieving this four times [2] 分组2 - The stock has underperformed, losing approximately 22.6% since the beginning of the year, compared to a decline of 4.7% for the S&P 500 [3] - The current consensus EPS estimate for the upcoming quarter is $0.45 on revenues of $350 million, and for the current fiscal year, it is $1.54 on revenues of $1.34 billion [7] - The Textile - Home Furnishing industry, to which Interface belongs, is currently ranked in the top 5% of over 250 Zacks industries, indicating a favorable outlook for the sector [8]

Core Viewpoint - Mohawk Industries reported quarterly earnings of $1.52 per share, exceeding the Zacks Consensus Estimate of $1.41 per share, but down from $1.86 per share a year ago, indicating a 7.80% earnings surprise [1][2] Financial Performance - The company posted revenues of $2.53 billion for the quarter, missing the Zacks Consensus Estimate by 1.84% and down from $2.68 billion year-over-year [2] - Over the last four quarters, Mohawk Industries has surpassed consensus EPS estimates four times and topped revenue estimates twice [2] Stock Performance - Mohawk Industries shares have declined approximately 10.7% since the beginning of the year, compared to a 5.3% decline in the S&P 500 [3] - The current Zacks Rank for Mohawk Industries is 4 (Sell), indicating expected underperformance in the near future [6] Earnings Outlook - The consensus EPS estimate for the upcoming quarter is $2.83 on revenues of $2.78 billion, and for the current fiscal year, it is $9.45 on revenues of $10.8 billion [7] - The trend of estimate revisions for Mohawk Industries has been unfavorable leading up to the earnings release [6] Industry Context - The Textile - Home Furnishing industry, to which Mohawk Industries belongs, is currently ranked in the top 11% of over 250 Zacks industries, suggesting a favorable industry outlook [8]